Beryllium announced today its formation as it recently finalized its consolidation of restructured assets from Emerald Bio and deCODE Genetics. With this restructuring, Beryllium emerges as a company positioned to address the market need for collaborative drug discovery.
Help employers find you! Check out all the jobs and post your resume.
